BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ercan A, Çelebier M, Oncul S, Varan G, Kocak E, Benito JM, Bilensoy E. Polycationic cyclodextrin nanoparticles induce apoptosis and affect antitumoral activity in HepG2 cell line: An evaluation at the molecular level. Int J Pharm 2021;598:120379. [PMID: 33592288 DOI: 10.1016/j.ijpharm.2021.120379] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Sun L, Chen L, Yang K, Dai WF, Yang Y, Cui X, Yang B, Wang C. A multiple functional supramolecular system for synergetic treatments of hepatocellular carcinoma. International Journal of Pharmaceutics 2022;619:121716. [DOI: 10.1016/j.ijpharm.2022.121716] [Reference Citation Analysis]
2 Aktanova A, Abramova T, Pashkina E, Boeva O, Grishina L, Kovalenko E, Kozlov V. Assessment of the Biocompatibility of Cucurbiturils in Blood Cells. Nanomaterials (Basel) 2021;11:1356. [PMID: 34063763 DOI: 10.3390/nano11061356] [Reference Citation Analysis]
3 Akkın S, Varan G, Aksüt D, Malanga M, Ercan A, Şen M, Bilensoy E. A different approach to immunochemotherapy for colon Cancer: Development of nanoplexes of cyclodextrins and Interleukin-2 loaded with 5-FU. Int J Pharm 2022;623:121940. [PMID: 35724824 DOI: 10.1016/j.ijpharm.2022.121940] [Reference Citation Analysis]